Canada Markets closed

Novamind Inc. (NVMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4079-0.0041 (-0.99%)
At close: 03:46PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.4120
Open0.3949
BidN/A x N/A
AskN/A x N/A
Day's Range0.3914 - 0.4079
52 Week Range0.3000 - 1.9000
Volume10,122
Avg. Volume22,791
Market Cap17.473M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1960
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Novamind to Participate in Citi's Psychedelic Drug Video Call Series

    TORONTO, ON / ACCESSWIRE / January 20, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that it will participate in Citi's Psychedelic Drug Video Call Series to be held virtually on January 25, 2022.

  • ACCESSWIRE

    Novamind Closes Arizona Acquisition

    Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.

  • ACCESSWIRE

    Novamind Hosts Pioneering Psychedelic Clinical Trial for Opioid Use Disorder

    TORONTO, ON / ACCESSWIRE / January 13, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced it will host a phase I randomized clinical trial for adults with opioid use disorder.